Maytansinoid DM4 is a cytotoxic agent that inhibits microtubule assembly by binding to tubulin at the rhizoxin binding site. It is a derivative of maytansine and is used as an active pharmaceutical ingredient in research and manufacturing contexts.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 799840-96-3
Ravtansine
pharmaceutical raw material
Sulfachlorpyridazine
pharmaceutical raw material
Sulfamethoxypyridazine
pharmaceutical raw material
Homatropine methylbromide
pharmaceutical raw material
Anisotropine methylbromide
pharmaceutical raw material
ANSAMITOCIN DERIV
pharmaceutical intermediate
[(1S,3S,5S,6S,16Z,18Z,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,2,5,9,16-pentamethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl] (2S)-2-[methyl-(4-methyl-4-sulfanylpentanoyl)amino]propanoate
SVVGCFZPFZGWRG-CFYIETIYSA-N
C/C/1=C/C=C\[C@H]([C@]2(C[C@@H](C([C@H]3[C@@](O3)([C@H](CC(=O)N(C4=C(C(=CC(=C4)C1)OC)Cl)C)OC(=O)[C@H](C)N(C)C(=O)CCC(C)(C)S)C)(C)C)OC(=O)N2)O)OC